久しぶりにサクッとナッツアレルギーについて調べてみた。新しいCDSRは追加されてなかった Allergen‐specific oral immunotherapy for peanut allergy Cochrane Systematic Review - Intervention Version published: 12 September 2012 https://t.co/hlzDRjaaN2

@JRB_UMFA Nothing new from the previous Cochrane meta analysis of peanut OIT concluded risk/benefit was unacceptable https://t.co/8irVTYLABX but with more evidence (aka patients) behind it.

RT @CochranePolska: Doustna immunoterapia swoista stosowana w alergii na orzeszki ziemne - co wiadomo, na podstaiwe badań, na temat... http…

Doustna immunoterapia swoista stosowana w alergii na orzeszki ziemne - co wiadomo, na podstaiwe badań, na temat... https://t.co/NKaMApABX2

@FrankQuintieri @jjgiablue @SheffStation 1/n Yep. Oral apprchs not new and small risk of AEs https://t.co/dL3PcY3POB https://t.co/OBl9b5pbQu

Allergen-specific oral immunotherapy for peanut allergy. http://t.co/eP1cn87D

Oral immunotherapy (OIT) not recommended for peanut allergy. http://t.co/Uq2m6R8n So thank goodness for helminths! http://t.co/bBFaREO4

MT@AllergyNet: Allergen-specific oral immunotherapy study for peanut allergy http://t.co/NKfw0E02 #foodallergy #OIT

“@AllergyNet: Cochrane: Allergen-specific oral immunotherapy for peanut allergy. Full details of the one included study http://t.co/cvuGGTI7

Cochrane: Allergen-specific oral immunotherapy for peanut allergy. Full details of the one included study http://t.co/RLuu5aYj

Cochrane: Allergen-specific oral immunotherapy for peanut allergy. Full details of the one included study http://t.co/RLuu5aYj

Allergen-specific oral immunotherapy for peanut allergy. http://t.co/tD0n7arm

Study doesn't recommend #peanut allergen oral immunotherapy; more studies required @allergiesweb @FoodAllergyBuzz http://t.co/kpJqiQ8R